4833X 15/1000 (Actoplus met XR 1000 mg / 15 mg)
Generic Name: metformin/pioglitazone
Pill imprint 4833X 15/1000 has been identified as Actoplus met XR 1000 mg / 15 mg.
ActoPlus Met XR is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. ActoPlus Met XR 1000 mg / 15 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- metformin/pioglitazone
- Imprint:
- 4833X 15/1000
- Strength:
- 1000 mg / 15 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Takeda Pharmaceuticals America
- National Drug Code (NDC):
- 64764-0510
- Inactive Ingredients:
- candelilla wax
cellulose acetate
povidone
hydroxypropyl cellulose (type h)
lactose monohydrate
magnesium stearate
hypromelloses
polyethylene glycol 400
polyethylene glycol 8000
sodium lauryl sulfate
titanium dioxide
triacetin
shellac
propylene glycol
ammonia
ferric oxide red
More about ActoPlus Met XR (metformin / pioglitazone)
Consumer resources
Professional resources
Other formulations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
